Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases-Reference-Cited by-同舟云学术

Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases

Published:2021-03-30 Issue: Volume: Page:
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Bosetti Cristina¹^ORCID,Santucci Claudia¹²,Pasina Luca³^ORCID,Fortino Ida⁴,Merlino Luca⁴,Corli Oscar⁵,Nobili Alessandro⁶

Affiliation:

1. Department of Oncology, Unit of Cancer Epidemiology Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy

2. Department of Clinical Sciences and Community Health Università degli Studi di Milano Milan Italy

3. Department of Neuroscience, Unit of Pharmacotherapy and Prescription Appropriateness Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy

4. Regional Ministry of Health, Lombardy Region Milan Italy

5. Department of Oncology, Unit of Pain and Palliative Care Research Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy

6. Department of Neuroscience, Laboratory for Quality Assessment of Geriatric Therapies and Services Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy

Funder

Regione Lombardia

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5223

Reference31 articles.

1. Polypharmacy in elderly patients;Hajjar ER;Am J Geriatr Pharmacother,2007

2. Drug therapy optimization at the end of life;Cruz‐Jentoft AJ;Drugs Aging,2012

3. Pharmacotherapy at the end‐of‐life;O'Mahony D;Age Ageing,2011